About ViaCord
ViaCord is a company based in Hebron (United States) founded in 1993 by Cynthia Fisher was acquired by PerkinElmer in October 2007.. ViaCord has raised $84.5 million across 3 funding rounds from investors including Amgen, PerkinElmer and Nomura. ViaCord offers products and services including Cord Blood Banking, Cord Tissue Banking, Genetic Insight Panel, and Whole Genome Sequencing. ViaCord operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Hebron, United States
- Founders Cynthia Fisher
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$84.5 M (USD)
in 3 rounds
-
Latest Funding Round
$20 M (USD), Series C
Dec 31, 2003
-
Investors
Amgen
& 8 more
-
Employee Count
Employee Count
-
Acquired by
PerkinElmer
(Oct 02, 2007)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ViaCord
ViaCord offers a comprehensive portfolio of products and services, including Cord Blood Banking, Cord Tissue Banking, Genetic Insight Panel, and Whole Genome Sequencing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service to collect and store umbilical cord blood stem cells.
Preserves cord tissue for potential regenerative treatments.
Analyzes genes for actionable health conditions in newborns.
Sequences genes to identify health risks and drug sensitivities.
Funding Insights of ViaCord
ViaCord has successfully raised a total of $84.5M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in December 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $20.0M
-
First Round
First Round
(14 Nov 2000)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2003 | Amount | Series C - ViaCord | Valuation |
investors |
|
| Feb, 2002 | Amount | Series C - ViaCord | Valuation |
investors |
|
| Nov, 2000 | Amount | Series C - ViaCord | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ViaCord
ViaCord has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Amgen, PerkinElmer and Nomura. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Healthcare investments are made by Tullis Health Investors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ViaCord
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ViaCord
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Viacord Comparisons
Competitors of ViaCord
ViaCord operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Cordlife is engaged in cord blood banking and diagnostics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Viacord
Frequently Asked Questions about ViaCord
When was ViaCord founded?
ViaCord was founded in 1993 and raised its 1st funding round 7 years after it was founded.
Where is ViaCord located?
ViaCord is headquartered in Hebron, United States. It is registered at Hebron, Connecticut, United States.
Is ViaCord a funded company?
ViaCord is a funded company, having raised a total of $84.5M across 3 funding rounds to date. The company's 1st funding round was a Series C of $48M, raised on Nov 14, 2000.
What does ViaCord do?
ViaCord was founded in 1993 in Hebron, United States, within the healthcare and biotechnology sectors. Cord blood from newborns umbilical cords is collected and stored by the company for potential future treatments of conditions like leukemias, immune deficiencies, and metabolic disorders. Genetic testing services are also made available to support therapeutic choices. Operations center on family preservation programs across the United States.
Who are the top competitors of ViaCord?
ViaCord's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does ViaCord offer?
ViaCord offers Cord Blood Banking, Cord Tissue Banking, Genetic Insight Panel, and Whole Genome Sequencing.
Who are ViaCord's investors?
ViaCord has 9 investors. Key investors include Amgen, PerkinElmer, Nomura, Genzyme, and Singapore Economic Development Board.